Influence of a Short Course of Ritonavir Used as Booster in Antiviral Therapies Against SARS-CoV-2 on the Exposure of Atorvastatin and Rosuvastatin

Publication
Cardiovasc Drugs Ther 2023
Click the respective buttons for more information.
Andreas D. Meid
Andreas D. Meid
Post-doctoral researcher in Clinical Pharmacology & Pharmacoepidemiology

My research interests include the study of appropriate drug therapy using methods of pharmacoepidemiology, quantitative pharmacology, and pharmacometrics.

Related